A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector. - Wikidata - awgldk - TriplyDB

A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.

A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.

http://www.wikidata.org/entity/Q36984591

about

Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity.Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery.Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing AAV's anatomy: roadmap for optimizing vectors for translational success Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives Immunization delivered by lentiviral vectors for cancer and infectious diseases.Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles.Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.piggyBac-mediated phenotypic correction of factor VIII deficiency Development of gene therapy for treatment of age-related macular degeneration.Efficient gene targeting mediated by a lentiviral vector-associated meganuclease Development of viral vectors for use in cardiovascular gene therapy.MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA.Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors.Clinical applications involving CNS gene transfer.Methods for gene transfer to the central nervous system.Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.A Hyperactive Transposase Promotes Persistent Gene Transfer of a piggyBac DNA Transposon Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.Development and use of SIV-based Integrase defective lentiviral vector for immunization.A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors.Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection.Integration-deficient lentiviral vectors: a slow coming of age.Integrase-defective lentiviral vectors: progress and applications.Integration-deficient lentiviral vectors expressing codon-optimized R338L human FIX restore normal hemostasis in Hemophilia B mice.Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells.Distribution and fate of HIV-1 unintegrated DNA species: a comprehensive update Recent advances in lentiviral vector development and applications.Hybrid lentiviral vectors.Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.Viral vectors for gene delivery to the central nervous system.Ocular gene delivery using lentiviral vectors.Lentiviral vectors in cancer immunotherapy.S/MAR sequence confers long-term mitotic stability on non-integrating lentiviral vector episomes without selection.Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo.

P2860

Q33564383-4FFF33E8-6C0F-43D1-8755-B50415AF70FE Q33633293-815E2225-E7E9-423E-AC0D-0F4F510A94DB Q33655722-BD415C18-68ED-4FB0-948D-BBE574EA8B51 Q33659389-71D72E98-51BF-4439-9CDE-1637233F25A0 Q34137546-811B3A64-4FDA-4C1B-BE3B-2A37EA162DBE Q34166320-D803E359-1E11-4846-B6DB-2B8760DC95C4 Q34206875-7310E699-BA37-4A68-B4B3-E747E79F9897 Q34467839-43E1E96F-3FD5-4521-86A0-97DD8076F230 Q34539879-EEBBB86D-BF78-4B87-965B-E212399E9A16 Q34621737-C0475E5E-C9B8-49A1-BC03-B13D95F099CC Q35069876-2E73EC9E-ADC7-4D0D-BED8-E3228C191360 Q35090661-5F769F8A-6B30-4E88-8BEE-F7E3061DE9E8 Q35144439-35FD06AF-7B4E-4969-A02F-35E56E10F3C4 Q35184221-A18EF17A-23C4-45B6-A1B5-7C7F5471EDDE Q35192906-B33CFE89-A1CF-448B-95F2-202953D6F4DA Q35224428-FEE115FA-AEB1-4B47-AB2A-28362054DF99 Q35260617-9BCBFE0E-3A6E-4214-A91A-DBCD5D0E2E76 Q35803106-AE89FD15-D819-4A89-8040-A3319B40169C Q35878409-E1778F14-283B-4CE7-8120-B28F9A862956 Q35899850-3BE72BC9-859A-40D2-88CE-C2436E46E44C Q35902332-3147215F-18C8-4294-AE62-0951B0567E6A Q36055898-AF6985FB-0CFF-4D0E-9C26-D2C5D1A3C050 Q36403754-9AB571FD-1248-4D5E-8B0E-0F298F785152 Q36469473-1036956D-A409-426B-9DCF-C93CF2173B1B Q37369322-72356644-8412-43A0-9435-3C75B7F20DC4 Q37406645-98347E1B-1801-4CEB-9DD7-913C41C05405 Q37413470-8EFA80F9-27CC-40EC-8E42-FC2CC239A3C8 Q37506025-74BD4343-BFE6-4E7B-8F0C-60771FDEE5AB Q37619239-F75899F1-B49C-4391-8D53-A055747216EF Q37620808-38865094-3BA2-44A2-A9F1-924C4538CD66 Q37620817-23E93CDA-82F8-4C8D-BF15-AEC59586A371 Q37649116-FCBAC4E4-8253-44C8-9697-E738AED2679F Q37678176-A6CE9B36-6AB0-4ECD-9A56-47BD818D98DB Q37734854-377954E9-6D9D-4AAE-AC95-D85C099FF803 Q37857291-18FF5B82-314F-4C36-954C-CCD33F5BEC19 Q37946113-8E7AC4BD-F8CF-4A87-94FD-29008F1BF74C Q37952564-916E6F95-CD99-4334-A6AA-7E054D1ED4CD Q38389312-39CEF8A4-A146-4F86-9547-AD7627B02AE3 Q38735841-2477A42B-3459-4B29-B58B-7E831D0F0208 Q39227747-5D76B89A-ADA1-427D-9543-C352C8095421

P2860

A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector.

http://www.wikidata.org/entity/Q36984591

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

A large U3 deletion causes inc ...... integrating lentiviral vector.

@en

type

label

A large U3 deletion causes inc ...... integrating lentiviral vector.

@en

prefLabel

A large U3 deletion causes inc ...... integrating lentiviral vector.

@en

P1433

Q36984591-CECF9525-9E84-4775-AD00-1A434EEBB92B

P1476

Q36984591-F0451BE0-4689-4F39-BC62-6D8D97DC1A98

P2093

Q36984591-0F6DCA63-A291-4277-9660-E946074EC80C

Q36984591-1CA1D8CC-4BA8-4B19-A659-D44004FCF8C9

Q36984591-5858370C-A9EC-4C4B-AD6E-6EDD07CA8F35

Q36984591-6854AA1C-0340-402F-8EAA-C8441DBB5DF0

Q36984591-8DA2766B-49DF-4D9E-AB2F-39187879D210

Q36984591-913CEFF8-E7C6-484F-B505-B0E8E6D17FD2

Q36984591-A718D340-BC31-4F19-8FB3-B26C96580F02

Q36984591-E289720E-A0F5-45ED-9C81-879C710D14FB

P2860

Q36984591-07CD7221-0537-45BC-9146-F4013783A2A1

Q36984591-1A401267-D438-4F92-9078-C25FC37EB63C

Q36984591-1F0BEDB8-572E-44C2-8458-E3C214A983A3

Q36984591-26CEC6F3-B437-4B75-BDF6-BACF500E3B4F

Q36984591-270285B8-014C-4C73-9BD7-52B69AEFA142

Q36984591-304AB336-D54A-44FC-9B38-F8C793E9D906

Q36984591-349B3184-0E50-4938-84D5-C097EAE6B61B

Q36984591-34BBAB31-F060-4914-8BAD-BE4A98D76937

Q36984591-381C1865-183D-4CE7-A986-2F715BFB05BD

Q36984591-38B6DD40-09E9-4ECE-AE25-51C3BE03FD42

P304

Q36984591-FB59A110-0D82-4244-A183-A0EB58DC48AA

P31

Q36984591-2C4FC62F-F1C9-40A2-8D7D-1CADD38E4FB8

P356

Q36984591-147BCF99-0C9C-4017-B068-3868C61D8FF1

P433

Q36984591-F7DF3100-553A-4B63-8A3E-CA7A92DF1BD5

P478

Q36984591-4BD8DFCD-CE4C-4641-A5BB-B22C7119DD16

P577

Q36984591-491E83B9-CEE6-403C-890C-8BF404A6A231

P5875

Q36984591-409198EC-DA7B-4AB5-A963-145B79D78748

P698

Q36984591-157CF3D6-847C-4B75-8A0A-EDE62A66897D

P932

Q36984591-9422FE6A-A014-424D-A4B8-41997620D587

P356

P1433

Molecular Therapy

P1476

A large U3 deletion causes inc ...... integrating lentiviral vector.

@en

P2093

Adam Cockrell

http://www.w3.org/2001/XMLSchema#string

Boris Kantor

http://www.w3.org/2001/XMLSchema#string

Brian Zeithaml

http://www.w3.org/2001/XMLSchema#string

Hong Ma

http://www.w3.org/2001/XMLSchema#string

Matthew Bayer

http://www.w3.org/2001/XMLSchema#string

Tal Kafri

http://www.w3.org/2001/XMLSchema#string

Thomas McCown

http://www.w3.org/2001/XMLSchema#string

Xiangping Li

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Selective extraction of polyoma DNA from infected mouse cell cultures

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Development of a self-inactivating lentivirus vector.

Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Structure of murine sarcoma virus DNA replicative intermediates synthesized in vitro.

Effective gene therapy with nonintegrating lentiviral vectors.

Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo.

The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

P304

1968-1976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2008.199

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23261135

http://www.w3.org/2001/XMLSchema#string

P698

18797449

http://www.w3.org/2001/XMLSchema#string

P932

2587457

http://www.w3.org/2001/XMLSchema#string